Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUGAR trial of sulodexide for endothelial glycocalyx damage in type 2 diabetes
NL-OMON24257Active, not recruiting
- Sponsor
- Alfa Wassermann
- Start
- Nov 2006
- Countries
- 1
01
Overview
Trial of sulodexide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Alfa Wassermann. Started Nov 2006; status: active, not recruiting.
02
Drugs
sulodexide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON24257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24257.